 This is a Phase III study in patients with melanoma that has spread to the lymph nodes andor a distant organ, and who have had all of their cancer surgically removed. The purpose of this study is to evaluate the ability of the CancerVaxTM vaccine to prevent or slow the recurrence of melanoma. 